| scholarly article | Q13442814 |
| P356 | DOI | 10.4155/FMC.10.211 |
| P8608 | Fatcat ID | release_jlasuix72vahrpn33hpgicllie |
| P698 | PubMed publication ID | 21426155 |
| P50 | author | Rolf Hilgenfeld | Q28039171 |
| P2860 | cites work | Rhinovirus chemotherapy | Q36468395 |
| Potential use of antiviral agents in polio eradication | Q36944919 | ||
| Selective inhibitors of picornavirus replication | Q37125475 | ||
| A case for developing antiviral drugs against polio | Q37177805 | ||
| The 3-D structure of HIV-1 proteinase and the design of antiviral agents for the treatment of AIDS. | Q38025214 | ||
| Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. | Q39967863 | ||
| Identification of SARS-like coronaviruses in horseshoe bats (Rhinolophus hipposideros) in Slovenia | Q40364182 | ||
| Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode | Q41884048 | ||
| Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events | Q42015742 | ||
| Enterovirus 71 outbreak in the People's Republic of China in 2008. | Q43097104 | ||
| An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. | Q43408886 | ||
| Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans | Q43431450 | ||
| Structure-based design of a parallel synthetic array directed toward the discovery of irreversible inhibitors of human rhinovirus 3C protease. | Q43977102 | ||
| HIVdb: a database of the structures of human immunodeficiency virus protease | Q45730318 | ||
| Antiviral therapy: quo vadis? | Q51721067 | ||
| Stable Benzotriazole Esters as Mechanism-Based Inactivators of the Severe Acute Respiratory Syndrome 3CL Protease | Q58239652 | ||
| The emerging academic drug-discovery sector | Q58867714 | ||
| Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia | Q24558699 | ||
| The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic | Q24655011 | ||
| Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradication | Q24683132 | ||
| Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes | Q27619756 | ||
| Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain | Q27639290 | ||
| Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs | Q27641252 | ||
| The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor | Q27642450 | ||
| A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters | Q27650857 | ||
| Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc-coordinating and Peptidomimetic Compounds | Q27653428 | ||
| Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease | Q27666447 | ||
| Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease | Q27696384 | ||
| Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1 | Q27702268 | ||
| On the size of the active site in proteases. I. Papain | Q27860826 | ||
| Identification of a new human coronavirus | Q29615906 | ||
| Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein | Q30194279 | ||
| Recent advances in targeting viral proteases for the discovery of novel antivirals | Q30227292 | ||
| The VIZIER project: preparedness against pathogenic RNA viruses | Q30229225 | ||
| Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor. | Q30448643 | ||
| Detection and prevalence patterns of group I coronaviruses in bats, northern Germany | Q30491762 | ||
| An efficient method for the synthesis of peptide aldehyde libraries employed in the discovery of reversible SARS coronavirus main protease (SARS-CoV Mpro) inhibitors | Q33243091 | ||
| Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar | Q33310740 | ||
| A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication | Q33375590 | ||
| Design of chemical libraries with potentially bioactive molecules applying a maximum common substructure concept | Q33494087 | ||
| Distant relatives of severe acute respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats, Ghana | Q33644581 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 1061-1067 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Future Medicinal Chemistry | Q19280078 |
| P1476 | title | Structure-based antivirals for emerging and neglected RNA viruses: an emerging field for medicinal chemistry in academia | |
| P478 | volume | 2 |
Search more.